Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronomic Oral Vinorelbine + Aromatase Inhibitors in Advanced Breast Cancer
NCT02730091Phase 3Terminated
- Sponsor
- CHU de Besançon
- Start
- Feb 2016
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vinorelbine in breast cancer, sponsored by CHU de Besançon. Started Feb 2016; status: terminated.
02
Drugs
vinorelbine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02730091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02730091.